- Home
- Letter to President Obama
- Acknowledgements
- Executive Summary
- Preface
- Part 1: The Case for HPV Vaccination
- Part 2: Urgency for Action
- Part 3: Accelerating HPV Vaccine Uptake in the U.S.
- Goal 1: Reduce Missed Clinical Opportunities
- Goal 2: Increase Acceptance of HPV Vaccines
- Goal 3: Maximize Access to HPV Vaccination Services
- Part 4: Increasing Global HPV Vaccination
- Part 5: High-Priority Research
- Conclusions
- Appendices
- Acronyms
PART 3
ACCELERATING HPV VACCINE UPTAKE IN THE U.S.
Experiences in some states and several other countries demonstrate that much higher uptake of HPV vaccines is possible. Lessons learned from the introduction of other vaccines and from a large literature on vaccine uptake show that widespread adoption of HPV vaccines is not likely to occur without comprehensive, targeted interventions aimed at providers, parents or other caregivers, and adolescents. The Panel recommends three critical goals that must be achieved to increase uptake of HPV vaccines in the United States, with the ultimate goal being completion of the full three-dose vaccine series by all age-eligible adolescents for whom the vaccine is not contraindicated. Particular attention should be paid to areas with high cervical cancer incidence rates and low HPV vaccine uptake. Figure 6 illustrates some of the audiences and objectives key to achieving these goals.
